Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Control Release ; 233: 208-19, 2016 07 10.
Artigo em Inglês | MEDLINE | ID: mdl-27178810

RESUMO

Influenza infection typically initiates at respiratory mucosal surfaces. Induction of immune responses at the sites where pathogens initiate replication is crucial for the prevention of infection. We studied the adjuvanticity of GPI-anchored CCL28 co-incorporated with influenza HA-antigens in chimeric virus-like particles (cVLPs), in boosting strong protective immune responses through an intranasal (i.n.) route in mice. We compared the immune responses to that from influenza VLPs without CCL28, or physically mixed with soluble CCL28 at systemic and various mucosal compartments. The cVLPs containing GPI-CCL28 showed in-vitro chemotactic activity towards spleen and lung cells expressing CCR3/CCR10 chemokine receptors. The cVLPs induced antigen specific endpoint titers and avidity indices of IgG in sera and IgA in tracheal, lung, and intestinal secretions, significantly higher (4-6 fold) than other formulations. Significantly higher (3-5 fold) hemagglutination inhibition titers and high serum neutralization against H3N2 viruses were also detected with CCL28-containing VLPs compared to other groups. The CCL28-containing VLPs showed complete and 80% protection, when vaccinated animals were challenged with A/Aichi/2/1968/H3N2 (homologous) and A/Philippines/2/1982/H3N2 (heterologous) viruses, respectively. Thus, GPI-anchored CCL28 in influenza VLPs act as a strong immunostimulator at both systemic and mucosal sites, boosting significant cross-protection in animals against heterologous viruses across a large distance.


Assuntos
Antígenos Virais/administração & dosagem , Quimiocinas CC/administração & dosagem , Proteínas Ligadas por GPI/administração & dosagem , Hemaglutininas Virais/administração & dosagem , Vírus da Influenza A Subtipo H3N2/imunologia , Vacinas de Partículas Semelhantes a Vírus/administração & dosagem , Proteínas da Matriz Viral/administração & dosagem , Administração Intranasal , Animais , Anticorpos Antivirais/imunologia , Linhagem Celular , Cães , Feminino , Imunoglobulina A/imunologia , Imunoglobulina G/imunologia , Células Madin Darby de Rim Canino , Camundongos Endogâmicos BALB C , Infecções por Orthomyxoviridae/prevenção & controle , Spodoptera
2.
EBioMedicine ; 5: 46-58, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27077111

RESUMO

Dendritic cells (DCs) are major antigen-presenting cells that can efficiently prime and cross-prime antigen-specific T cells. Delivering antigen to DCs via surface receptors is thus an appealing strategy to evoke cellular immunity. Nonetheless, which DC surface receptor to target to yield the optimal CD8(+) and CD4(+) T cell responses remains elusive. Herein, we report the superiority of CD40 over 9 different lectins and scavenger receptors at evoking antigen-specific CD8(+) T cell responses. However, lectins (e.g., LOX-1 and Dectin-1) were more efficient than CD40 at eliciting CD4(+) T cell responses. Common and distinct patterns of subcellular and intracellular localization of receptor-bound αCD40, αLOX-1 and αDectin-1 further support their functional specialization at enhancing antigen presentation to either CD8(+) or CD4(+) T cells. Lastly, we demonstrate that antigen targeting to CD40 can evoke potent antigen-specific CD8(+) T cell responses in human CD40 transgenic mice. This study provides fundamental information for the rational design of vaccines against cancers and viral infections.


Assuntos
Apresentação de Antígeno/imunologia , Ligante de CD40/imunologia , Células Dendríticas/imunologia , Imunoterapia Ativa , Ativação Linfocitária/imunologia , Animais , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Diferenciação Celular/imunologia , Humanos , Lectinas/imunologia , Lectinas Tipo C/imunologia , Camundongos , Camundongos Transgênicos , Proteínas Recombinantes de Fusão/imunologia , Receptores Depuradores Classe E/imunologia
3.
J Synchrotron Radiat ; 18(Pt 5): 743-6, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21862854

RESUMO

Liquid water produced in a polymer electrolyte membrane fuel cell experiences a freeze/thaw cycle when the cell is switched off and on while operating at ambient temperatures below freezing. This freeze/thaw cycle permanently deforms the polymer electrolyte membrane fuel cell capillary structures and reduces both the cell life and its ability to generate electric power. The X-ray tomography facility at the Pohang Accelerator Laboratory was used to observe the freeze/thaw effects on the gas diffusion layer (GDL), which is the thickest capillary layer in the cell. Morphological changes in the GDL under a water freeze/thaw cycle were observed. A scenario in which freeze/thaw cycles affect fuel cell performance is suggested based on images from X-ray tomography.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA